Valentina Mancioppi Erica Pozzi Sara Zanetta Anna Missineo Silvia Savastio Fabrizio Barbetti Simona Mellone Mara Giordano Ivana Rabbone
10.3389/fendo.2023.1143736
Front Endocrinol (Lausanne)
2023 May 11;14:1143736.
kcnj11 continuous subcutaneous insulin infusion (csii) glibenclamide hyperglycemia monogenic diabetes neonatal diabetes mellitus (ndm)
CC BY
https://pubmed.ncbi.nlm.nih.gov/37251668/
Diabetes Mellitus / diagnosis Diabetes Mellitus / drug therapy Diabetes Mellitus / genetics Infant, Newborn, Diseases / drug therapy Infant, Newborn, Diseases / genetics Potassium Channels, Inwardly Rectifying / genetics
Diabetes Mellitus / diagnosis Diabetes Mellitus / drug therapy Diabetes Mellitus / genetics Infant, Newborn, Diseases / drug therapy Infant, Newborn, Diseases / genetics Potassium Channels, Inwardly Rectifying / genetics Case Reports Blood Glucose Blood Glucose Self-Monitoring Glyburide / therapeutic use Humans Hypoglycemic Agents / therapeutic use Infant Infant, Newborn Insulin / therapeutic use Male Sulfonylurea Compounds / therapeutic use Glyburide Hypoglycemic Agents Potassium Channels, Inwardly Rectifying Blood Glucose Insulin Sulfonylurea Compounds
PMC10211331
37251668
Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
2023